It is doubtful that the study will do much to reassure parents, however, some of whom continue to believe passionately that their child's autism was a direct consequence of childhood vaccinations despite research findings to the contrary.
Friday, January 11, 2008
Thimerosal and Autism
The results of a study by researchers at the Department of Public Health in California do not support the hypothesis that autism is caused by thimerosal, a preservative containing ethylmercury that was once used in childhood vaccines. The researchers found that the incidence of autism rose steadily in California from 1995 to 2007, even though thimerosal was removed from most childhood vaccines in 2001. If thimerosal were responsible for causing autism there should have been a sharp decline in new cases of autism after 2004. The new findings and a commentary about them are published in The Archives of General Psychiatry.
Thursday, January 3, 2008
The Limits of Science
The free online version of the New York Times has a recent article that could be used to start a discussion in your Human Biology classroom about the limits of science. (“Both Sides Cite Science to Address Altered Corn”, Dec. 26, 2007, nytimes.com). In this case, Europeans are arguing over whether or not to ban the planting of a pest-resistant strain of genetically modified (GM) corn.
Interestingly, both sides are trying to justify their position on the basis of science. Those opposing the planting of the GM corn argue that one can never be absolutely certain that the new corn is completely safe. They are right, of course; science cannot absolutely prove GM corn’s safety under all known (and as yet unknown!) conditions. On the other hand, those in favor of planting the GM corn argue that according to the currently available scientific evidence, GM corn is “unlikely” to pose a significant risk. They are right, too.
Ultimately, the decision of whether or not to ban GM corn will be a public policy decision based not only on the available scientific data, but also on political, economic, and social pressures. Nevertheless, science certainly does have an important role in issues such as this. Points of concern raised during public debate can perhaps be tested by science, improving our confidence in public policy decisions both now and in the future.
Interestingly, both sides are trying to justify their position on the basis of science. Those opposing the planting of the GM corn argue that one can never be absolutely certain that the new corn is completely safe. They are right, of course; science cannot absolutely prove GM corn’s safety under all known (and as yet unknown!) conditions. On the other hand, those in favor of planting the GM corn argue that according to the currently available scientific evidence, GM corn is “unlikely” to pose a significant risk. They are right, too.
Ultimately, the decision of whether or not to ban GM corn will be a public policy decision based not only on the available scientific data, but also on political, economic, and social pressures. Nevertheless, science certainly does have an important role in issues such as this. Points of concern raised during public debate can perhaps be tested by science, improving our confidence in public policy decisions both now and in the future.
Wednesday, December 19, 2007
The Concept of Sustainability in Agriculture
An article in the New York Times free online edition this week discusses two possible examples of what might turn out to be unsustainable modern agricultural practices (“Our Decrepit Food Factories”, by Michael Pollan. nytimes.com, Dec. 16). Mr. Pollan suggests that MRSA (methicillin-resistant Staphylococcus aureas) infections in humans may become more common due to the widespread use of antibiotics in pig feed. He also presents some good arguments for why the worldwide collapse of honeybee populations may be due in part to unsustainable modern farming practices that stress the bees.
It makes for easy reading at the student level. The article could be used to spark a discussion about how best to actually achieve agricultural sustainability in the face of pressures to produce more food for a growing world population.
It makes for easy reading at the student level. The article could be used to spark a discussion about how best to actually achieve agricultural sustainability in the face of pressures to produce more food for a growing world population.
Thursday, December 13, 2007
Cancer Therapy
The January issue of Scientific American, now available in electronic form, will have an interesting article about how antiangiogenic drugs (drugs that inhibit blood vessel growth) such as Avastin actually work in cancer therapy. It turns out that it’s not just that they reduce the overall blood supply to a tumor, although that is one of their actions. In fact, they also normalize the remaining vessels, pruning them and improving their permeability properties. As a result, antiangiogenic drugs improve the effectiveness of other cancer treatments such as chemotherapy, because now the chemotherapeutic drugs are better able to reach the tumor cells.
But there is only a window of opportunity in which the combination of antioangiogenic drugs and other therapies is particularly effective, because the antiangiogenic drugs are hard on blood vessels throughout the body and because tumors may eventually lose their responsiveness to the drugs. Nevertheless, our improved understanding of how antiangiogenic drugs actually work is opening new avenues for developing more specific cancer treatment regimens. To learn more, read the original article (“Taming Vessels to Treat Cancer”, by Rakesh K. Jain. Scientific American Jan. 2008, pp. 56-63).
But there is only a window of opportunity in which the combination of antioangiogenic drugs and other therapies is particularly effective, because the antiangiogenic drugs are hard on blood vessels throughout the body and because tumors may eventually lose their responsiveness to the drugs. Nevertheless, our improved understanding of how antiangiogenic drugs actually work is opening new avenues for developing more specific cancer treatment regimens. To learn more, read the original article (“Taming Vessels to Treat Cancer”, by Rakesh K. Jain. Scientific American Jan. 2008, pp. 56-63).
Thursday, December 6, 2007
Stem Cell Breakthrough
In late November Dr. Shimya Yamanaka reported in Cell that he had produced human stem cells from adult human cells taken from the cheek of a middle-aged woman. On the same day, Dr. James Thomson reported in the online version of Science that he had achieved similar success with foreskin cells from newborns.
Scientists are hailing these two reports as a technical breakthrough in stem cell research. The key is that these two researchers derived their stem cells from older cells, NOT from embryonic cells. Stem cell research has always been highly controversial because most of the stem cells used in research come from human embryos (see the Current Issue in Human Biology 5th ed., pp. 72-73). But if human stem cells can be created from older cells without sacrificing human embryos, then the whole “sanctity-of-life” issue is off the table. An added benefit is that if a simple cheek cell can be used, then stem cells could be grown specifically for any patient, using cells taken from that patient.
It’s way too early to think of growing a new heart for a patient in heart failure from his/her own cells, though. Although these new findings show that we have reached a basic level of understanding of how to create stem cells, we don’t yet understand how to direct them into becoming the specific human organs or tissues we might need to treat disease. Many scientists, including Dr. Yamanaka and his colleagues, argue that it would be “a serious mistake” to move too quickly to end all embryonic stem cell research, based on these very first successes at creating stem cells from adult cells. They believe that embryonic stem cells are still likely to be necessary for decades to come.
Still, it’s encouraging to think that in our lifetimes, the controversy over stem cell research may just slowly disappear.
Scientists are hailing these two reports as a technical breakthrough in stem cell research. The key is that these two researchers derived their stem cells from older cells, NOT from embryonic cells. Stem cell research has always been highly controversial because most of the stem cells used in research come from human embryos (see the Current Issue in Human Biology 5th ed., pp. 72-73). But if human stem cells can be created from older cells without sacrificing human embryos, then the whole “sanctity-of-life” issue is off the table. An added benefit is that if a simple cheek cell can be used, then stem cells could be grown specifically for any patient, using cells taken from that patient.
It’s way too early to think of growing a new heart for a patient in heart failure from his/her own cells, though. Although these new findings show that we have reached a basic level of understanding of how to create stem cells, we don’t yet understand how to direct them into becoming the specific human organs or tissues we might need to treat disease. Many scientists, including Dr. Yamanaka and his colleagues, argue that it would be “a serious mistake” to move too quickly to end all embryonic stem cell research, based on these very first successes at creating stem cells from adult cells. They believe that embryonic stem cells are still likely to be necessary for decades to come.
Still, it’s encouraging to think that in our lifetimes, the controversy over stem cell research may just slowly disappear.
Friday, November 16, 2007
Barry Bonds Indicted
Home run king Barry Bonds was indicted this week on felony charges that could send him to prison for at least a decade. Bonds is charged with lying under oath to a federal grand jury back in 2003. Bonds has always claimed that he never knowingly used performance-enhancing steroids, but government investigators now say they can prove that Mr. Bonds used steroids, based on a positive blood test seized during an investigation of a California laboratory that sells them. Bond’s lawyer calls the charges “ridiculous”. The case may drag on in the courts for years. In the meantime, many baseball fans will consider Bonds’ home run record to have an asterisk after it.
The dangers of steroid abuse by athletes are discussed in Human Biology 5th ed., pp. 134-135.
The dangers of steroid abuse by athletes are discussed in Human Biology 5th ed., pp. 134-135.
Thursday, November 15, 2007
Birth Control Pills on Campus, Revisited
Previously I reported that sweeping changes in Medicaid reimbursement rules were likely to have the unintended consequence of causing a sharp increase in the cost of birth control pills on college campuses this past Fall (see this blog, July 24, 2007 posting). Indeed, the cost of birth control pills on many campuses did go up, on some campuses by as much as 10-fold. Some college health clinics stopped providing birth control pills entirely.
Fortunately, relief is in sight. Introduced by Representative Joseph Crowley of New York and backed by over 100 co-sponsors on both sides of the aisle, the Prevention Through Affordable Access Act (HR 4054) would restore the ability of college health clinics and safety-net health care providers to buy birth control pills at discounted rates and to pass those savings on to college women and other women in need.
Apparently the word “prevention” in the Prevention Through Affordable Access Act stands for prevention of unintended pregnancy. According to a press release from his office, Representative Crowley states that “A bureaucratic mistake should not stand in the way of protecting the health and safety of hard-working women. My colleagues, who are interested in effectively preventing unintended pregnancies, ought to support this measure and join us in urging its immediate passage.” Well said, Congressman Crowley.
Do your students understand the legislative process? Are they interested in how specific legislation (this one is a good example) might affect them personally? How do they feel about this particular bill?
Fortunately, relief is in sight. Introduced by Representative Joseph Crowley of New York and backed by over 100 co-sponsors on both sides of the aisle, the Prevention Through Affordable Access Act (HR 4054) would restore the ability of college health clinics and safety-net health care providers to buy birth control pills at discounted rates and to pass those savings on to college women and other women in need.
Apparently the word “prevention” in the Prevention Through Affordable Access Act stands for prevention of unintended pregnancy. According to a press release from his office, Representative Crowley states that “A bureaucratic mistake should not stand in the way of protecting the health and safety of hard-working women. My colleagues, who are interested in effectively preventing unintended pregnancies, ought to support this measure and join us in urging its immediate passage.” Well said, Congressman Crowley.
Do your students understand the legislative process? Are they interested in how specific legislation (this one is a good example) might affect them personally? How do they feel about this particular bill?
Subscribe to:
Posts (Atom)